$7 million NIH grant awarded for testing advancing sequencing tools
The National Center for Advancing Translational Sciences (NCATS) and the All of Us Research Program (both part of the NIH) announced a $7 million award to HudsonAlpha Institute for Biotechnology, Huntsville, Alabama to evaluate the use of leading-edge DNA sequencing technologies. The funds will hopefully improve diagnosis and treatment in a variety of diseases.
The National Center for Advancing Translational Sciences (NCATS) and the All of Us Research Program (both part of the NIH) announced a $7 million award to HudsonAlpha Institute for Biotechnology, Huntsville, Alabama to evaluate the use of leading-edge DNA sequencing technologies. The funds will hopefully improve diagnosis and treatment in a variety of diseases.
New reference genome helps understand diversity
Houston, TX – At the American Society of Human Genetics 2019 Annual Meeting scientists shared results from the new human reference genome project. The new sequences improve the utility of the human reference genome, a touchstone resource for modern genetics and genomics research. There is a need to improve the reference to better capture genetic diversity among different human populations.
Houston, TX – At the American Society of Human Genetics 2019 Annual Meeting scientists shared results from the new human reference genome project. The new sequences improve the utility of the human reference genome, a touchstone resource for modern genetics and genomics research. There is a need to improve the reference to better capture genetic diversity among different human populations.
NIH research shows racial disparities in grant awards
According to a new study by National Institutes of Health (NIH) scientists, published in Science Advances on October 9, research topic preference accounts for more than 20% of a persistent funding gap for black scientists applying for National Institutes of Health research project (R01) grants compared to white scientists. Each step of the application submission and review processes for R01 applications were examined between 2011-2015.
According to a new study by National Institutes of Health (NIH) scientists, published in Science Advances on October 9, research topic preference accounts for more than 20% of a persistent funding gap for black scientists applying for National Institutes of Health research project (R01) grants compared to white scientists. Each step of the application submission and review processes for R01 applications were examined between 2011-2015.
UC Davis awarded grant for Oral CRISPR treatment
UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health (NIH) to start work of a novel approach to deliver CRISPR genome-editing machinery to gut cells in a way that will fix genes responsible for a rare form of familial cancer. The research team hopes that this work will lead to new treatments for diseases of the gut.
UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health (NIH) to start work of a novel approach to deliver CRISPR genome-editing machinery to gut cells in a way that will fix genes responsible for a rare form of familial cancer. The research team hopes that this work will lead to new treatments for diseases of the gut.
EMBO & ASAPbio unite with new preprints platform
EMBO Press and ASAPbio announced on September 30, 2019, that they have partnered to create Review Commons, a brand-new platform to facilitate preprint peer review prior to manuscript submission. The site will be launched in December 2019.
EMBO Press and ASAPbio announced on September 30, 2019, that they have partnered to create Review Commons, a brand-new platform to facilitate preprint peer review prior to manuscript submission. The site will be launched in December 2019.
FDA restructures to support new drug development
The U.S. Food and Drug Administration announced on September 26, 2019 that the Center for Drug Evaluation and Research (CDER) reorganization has been approved. The reorganization will take place within certain offices of New Drugs Regulatory Program (NDRP).
The U.S. Food and Drug Administration announced on September 26, 2019 that the Center for Drug Evaluation and Research (CDER) reorganization has been approved. The reorganization will take place within certain offices of New Drugs Regulatory Program (NDRP).
GE launches super-resolution microscope
GE Healthcare announced the newest addition to their collection of microscopes, the DeltaVision OMX Flex super-solution microscope, on September 18. EDGE confocal technology will help researchers view cells in extreme detail without compromising speed, depth or clarity. The microscope uses structured illumination microscopy (SIM), a highly stable, multichannel imaging platform integrated with EDGE technology. Discuss
GE Healthcare announced the newest addition to their collection of microscopes, the DeltaVision OMX Flex super-solution microscope, on September 18. EDGE confocal technology will help researchers view cells in extreme detail without compromising speed, depth or clarity. The microscope uses structured illumination microscopy (SIM), a highly stable, multichannel imaging platform integrated with EDGE technology. Discuss
NIH funds human genome reference update
The National Institutes of Health announced on September 24 that it will be granting $29.5 million to support researchers to generate and maintain the most comprehensive reference of the human genome. The funds, distributed over the course of five years, will be managed by the National Human Genome Research Institute (NHGRI). Discuss
The National Institutes of Health announced on September 24 that it will be granting $29.5 million to support researchers to generate and maintain the most comprehensive reference of the human genome. The funds, distributed over the course of five years, will be managed by the National Human Genome Research Institute (NHGRI). Discuss
Innoplexus & ChemAxon partner on life science data
Innoplexus announces an official partnership with ChemAxon on September 20, to enable companies to find and connect information in the pharmaceutical and biotechnology industries. This venture will enrich life science research by allowing pharma and biotech companies to be innovative and faster in developing novel therapies. Discuss
Innoplexus announces an official partnership with ChemAxon on September 20, to enable companies to find and connect information in the pharmaceutical and biotechnology industries. This venture will enrich life science research by allowing pharma and biotech companies to be innovative and faster in developing novel therapies. Discuss
Bruker & Murdoch University strategic collaboration announced for phenomics
On Friday, September 20, 2019, Murdoch University (Perth, Australia) and Bruker (Billerica, Massachusetts) announced a strategic collaboration to transform the prevention and diagnosis of disease and personalized health. The efforts will be focused within the Australian National Phenome Centre (ANPC), an international center of expertise for metabolic phenotyping.
On Friday, September 20, 2019, Murdoch University (Perth, Australia) and Bruker (Billerica, Massachusetts) announced a strategic collaboration to transform the prevention and diagnosis of disease and personalized health. The efforts will be focused within the Australian National Phenome Centre (ANPC), an international center of expertise for metabolic phenotyping.